The Cabinet of Ministers has changed the procedure for medical institutions to work with narcotic drugs, psychotropic substances, and precursors. The new rules are intended to make the system safer, more modern, and more controlled — from the purchase of drugs to their use and disposal.
The Ukrainian healthcare system has received another update of the rules that concern a particularly sensitive area — the circulation of narcotic drugs, psychotropic substances and precursors in medical institutions.
On May 1, 2026, the Cabinet of Ministers adopted Resolution No. 560, which updated the current procedure for working with such drugs in hospitals, clinics and other healthcare institutions. These are changes to the basic document that has been in effect since 2013, but is now adapting to modern medical realities and new control requirements.
Simply put, the state has revised the rules for how medical institutions must purchase, transport, store, prescribe, use and destroy drugs containing narcotic or psychotropic components.
Why is this important? Because such substances are both critically necessary for medicine — for example, in pain relief, palliative care, anesthesia or treatment of serious conditions — and at the same time require particularly strict control due to the risks of illegal use.
The updated procedure has several key goals. First, to increase the safety and transparency of medical institutions’ work with controlled drugs. Second, to simplify certain processes where the old system no longer met the real needs of hospitals. Third, to bring the regulation into line with modern healthcare requirements.
In practice, this means that medical institutions must keep even more accurate records of such drugs, adhere to updated storage and transportation procedures, and ensure proper documentation of each stage — from receipt to disposal.
For patients, the changes primarily mean greater orderliness of the system. This is important for those who need strong painkillers, in particular in oncology, postoperative medicine or palliative care. More effective regulation can help avoid both shortages of necessary drugs and the risks of their inappropriate use.
For medical institution management and pharmaceutical staff, this means the need to monitor internal procedures, documentation, and compliance with new regulations more closely.
It is worth noting that such changes are not only about control, but also about balance. The state is trying to simultaneously ensure patients’ access to necessary treatment and strengthen safeguards against abuse.
In today’s conditions, when the healthcare system is working under heavy load, updating the rules should make the management of such drugs more efficient and safe.
In conclusion, Resolution No. 560 is another step towards the modernization of the medical system of Ukraine. It does not change the very essence of the use of narcotic or psychotropic substances in medicine, but updates the rules of the game so that they meet today’s challenges: safety, control, accessibility and clear regulation.
Посилання скопійовано